Humacyte to Participate in Fireside Chat at Cowen 6th Annual FutureHealth Conference
DURHAM, N.C., June 10, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced that Laura Niklason, M.D., Ph.D., Chief Executive Officer, and Dale Sander, Chief Financial Officer, will participate in a fireside chat on regenerative medicine at the Cowen 6th Annual FutureHealth Conference taking place virtually on June 16, 2021, at 10 a.m. EDT.
The webcast will be available for replay for 30 days following the presentation and can be accessed at www.Humacyte.com.
On February 17, 2021, Alpha Healthcare Acquisition Corp. (Nasdaq: AHAC) (“AHAC”), a special purpose acquisition company, and Humacyte announced the execution of a definitive business combination agreement along with a fully committed $175 million PIPE financing agreement.
About Alpha Healthcare Acquisition Corp.
Important Information About the Merger and Where to Find It
Participants in the Solicitation
Humacyte Investor Contact:
Humacyte Media Contact:
Myth vs. Reality: The Truth About AI and CX
Use Case Theatre